SMMT CIK: 1599298

Summit Therapeutics Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY24
billions USD
FY21:
0.02
FY22:
0.02
FY23:
0.00
FY24:
0.00
FY25:
–
(positive)
Change from FY21 to FY24
billions USD
FY21:
−0.09
FY22:
−0.07
FY23:
−0.61
FY24:
−0.23
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.09
FY22:
−0.08
FY23:
−0.61
FY24:
−0.22
FY25:
−1.08
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.09
FY22:
−0.08
FY23:
−0.61
FY24:
−0.22
FY25:
−1.08

All amounts in billions USD Data source:SEC EDGAR